These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Hemophagocytosis in hemophagocytic lymphohistiocytosis. Hindupur S Am J Hematol; 2005 Dec; 80(4):299-300. PubMed ID: 16315266 [No Abstract] [Full Text] [Related]
26. Cutaneous Crohn's disease in the pediatric population. Vaid RM; Cohen BA Pediatr Dermatol; 2010; 27(3):279-81. PubMed ID: 20609145 [TBL] [Abstract][Full Text] [Related]
27. Azathioprine discontinuation earlier than 6 months in Crohn's disease patients started on anti-TNF therapy is associated with loss of response and the need for anti-TNF dose escalation. Viazis N; Koukouratos T; Anastasiou J; Giakoumis M; Triantos C; Tsolias C; Theocharis G; Karamanolis DG Eur J Gastroenterol Hepatol; 2015 Apr; 27(4):436-41. PubMed ID: 25874518 [TBL] [Abstract][Full Text] [Related]
28. Cutaneous penile and perianal Crohn's disease treated with a combination of medical and surgical interventions. Rajpara SM; Siddha SK; Ormerod AD; Kerr KM; Kolhe PS Australas J Dermatol; 2008 Feb; 49(1):21-4. PubMed ID: 18186842 [TBL] [Abstract][Full Text] [Related]
29. Idiopathic bullous eosinophilic cellulitis (Wells syndrome) responsive to topical tacrolimus and antihistamine combination. Verma P; Singal A; Sharma S Indian J Dermatol Venereol Leprol; 2012; 78(3):378-80. PubMed ID: 22565446 [No Abstract] [Full Text] [Related]
30. SARS-COV-2 infection might cause transient cutaneous lesions in IBD patients under treatment with adalimumab. Tursi A; Tiano M J Gastrointestin Liver Dis; 2021 Jun; 30(2):310-311. PubMed ID: 34174058 [No Abstract] [Full Text] [Related]
31. [Predictors of efficacy, mucosal healing and dose intensification during the first year of adalimumab therapy in patients with luminal and fistulizing Crohn's disease. National data from Hungary]. Kiss LS; Szamosi T; Molnár T; Miheller P; Lakatos L; Vincze A; Palatka K; Bartha Z; Gasztonyi B; Salamon A; Horváth G; Tóth GT; Farkas K; Banai J; Tulassay Z; Nagy F; Szenes M; Veres G; Lovász BD; Végh Z; Golovics PA; Szathmári M; Papp M; Lakatos PL Orv Hetil; 2011 Sep; 152(36):1433-42. PubMed ID: 21865144 [TBL] [Abstract][Full Text] [Related]
32. Idiopathic ileocolitis with perforation associated with HIV infection: thalidomide treatment. Ramos JM; Masiá M; Durán R; Gutiérrez F Int J STD AIDS; 2012 Nov; 23(11):830-2. PubMed ID: 23155107 [TBL] [Abstract][Full Text] [Related]
33. Cutaneous Vasculitis Caused by Anti-Tumor Necrosis Factor Therapy: A Case Report. Shivaji UN; Awasthi AK; Aherne R Clin Gastroenterol Hepatol; 2016 Jan; 14(1):e1-2. PubMed ID: 25998787 [No Abstract] [Full Text] [Related]
38. Metastatic cutaneous Crohn's disease in a child. Dutheil P; Wallach D; Leibowitch M; Raynaud F; Dupont C J Pediatr Gastroenterol Nutr; 1998 Mar; 26(3):343-4. PubMed ID: 9523872 [No Abstract] [Full Text] [Related]
39. Cutaneous Crohn's disease. Teixeira M; Machado S; Lago P; Sanches M; Selores M Int J Dermatol; 2006 Sep; 45(9):1074-6. PubMed ID: 16961513 [No Abstract] [Full Text] [Related]
40. Wells' syndrome: report of a case and review of the literature. Weiss G; Shemer A; Confino Y; Kaplan B; Trau H Int J Dermatol; 2001 Feb; 40(2):148-52. PubMed ID: 11328401 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]